Government Patents Up for Grabs to Innovate and Profit
Published Date: 7/3/2025
Notice
Summary
The U.S. Government owns some cool inventions and is ready to license them to businesses eager to bring new ideas to life fast. Companies, both local and international, can grab these opportunities since some inventions have foreign patents too. If you’re a business looking to innovate, now’s the time to jump in and make money from these smart creations!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Government Inventions Open for Licensing
The U.S. Government owns certain inventions from federally funded research and is offering them for licensing so companies can commercialize the results faster. If you run a business, you can seek a license to develop and sell products based on these government-owned inventions.
Foreign Patents and Licensing Possibilities
For selected inventions, foreign patent applications have been filed to extend market coverage, and those foreign patents may also be available for licensing. If your business wants to operate or sell in international markets, these foreign patent filings could be licensed to support overseas commercialization.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-12454 — Interest Rate Paid on Cash Deposited to Secure U.S. Immigration and Customs Enforcement Immigration Bonds
Starting July 1, 2025, through September 30, 2025, if you put money down for an ICE immigration bond, you'll earn 3% interest per year on that cash. This update affects anyone who posts these bonds and means your money grows a bit while it’s held. Mark your calendar because this new rate kicks in mid-2025 and lasts for three months.
Next: 2025-12456 — Sunshine Act Meetings
The National Science Board is holding a quick, closed video meeting on July 7, 2025, to talk about their new 5-year plan for the National Science Foundation. This affects board members and anyone interested in NSF’s future strategy. No money changes are announced, but the meeting sets the stage for big decisions ahead.